Reproductive risks of cocaine

Human Reproduction Update

Volumn 2, Issue 1, 1996, Pages 43-55

  Rizk, Botros ^a   Atterbury, Jana L ^a   Groome, Lynn J ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Behaviour; Cocaine; Outcome; Pregnancy; Teratogenesis

Indexed keywords

COCAINE;

AMNION FLUID; BREATHING DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CENTRAL NERVOUS SYSTEM DISEASE; DRUG ABUSE; DRUG CLEARANCE; DRUG EFFECT; DRUG SCREENING; FETUS DEVELOPMENT; FETUS MALFORMATION; FETUS OUTCOME; HEALTH CARE COST; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; NEWBORN DISEASE; NONHUMAN; PERINATAL DEVELOPMENT; PHYSICAL CHEMISTRY; PREGNANCY; PREMATURE LABOR; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; TERATOGENESIS; UNITED STATES;

ABNORMALITIES, DRUG-INDUCED; AMNIOTIC FLUID; CARDIOVASCULAR SYSTEM; COCAINE; FEMALE; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 0029912168     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/2.1.43     Document Type: Review

References (119)

1. Amaro, H., Fried, L.E. and Cabral, H. (1990) Violence during pregnancy and substance use. Am. J. Public Health, 80, 575-579.
2. American College of Obstetricians and Gynecologists (1994) Substance abuse. Technical Bulletin, 194, 1-7.
3. Bailey, D.N. (1989) Drug screening in an unconventional matrix: hair analysis. J. Am. Med. Assoc., 262, 3331.
4. Bandstra, E.S. and Burkett, G. (1991) Maternal-fetal and neonatal effects of in utero cocaine exposure. Semin. Perinatol., 15, 288-301.
5. Bauchner, H., Zuckerman, B., McClain, M., Frank, D., Fried, L.E. and Kayne, H. (1988) Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J. Pediatr., 113, 831-834.
6. Bayley, N. (1969) Bayley Scales of Infant Development. Psychological Corporation, New York, NY, USA.
7. Bayorh, M.A., Zukowska-Grojec, Z. and Koplin, I.J. (1983) Effect of desipramine and cocaine on plasma norepinephrine and pressor response to adrenergic stimulation in pithed rats. J. Clin. Pharmacol., 23, 24-31.
8. Bingol, N., Fuchs, M., Diaz, V., Stone, R.K. and Gromisch, D.S. (1987) Teratogenicity of cocaine in humans. J. Pediatr., 110, 93-96.
9. Bracken, M.B., Eskenazi, B., Sachse, K., McSharry, J.E., Hellenbrand, K. and Leo-Summers, L. (1990) Association of cocaine use with sperm concentration motility and morphology. Fertil. Steril., 53, 315-322.
10. Brazelton, T.B. (1984) Neonatal Behavioral Assessment Scale. Spastics International Medical Publications, Philadelphia, PA, USA.
11. Broekhuizen, F.F., Utrie, J. and Van Mullem, C. (1992) Drug use or inadequate prenatal care? Adverse pregnancy outcome in an urban setting. Am. J. Obstet. Gynecol., 166, 1747-1756.
12. Burkett, G., Yasin, S.Y., Palow, D., LaVoie, L. and Martinez, M. (1994) Patterns of cocaine bingeing effect on pregnancy. Am. J. Obstet. Gynecol., 171, 372-379.
13. Buyukunal, C., Kilic, N., Dervisoglu, S. and Altug, T. (1994) Maternal cocaine abuse resulting in necrotizing enterocolitis: an experimental study in a rat model. Acta Paediatr. (Suppl.), 396, 91-93.
14. Chan, K., Dodd, P.A., Day, L., Kullama, L., Ervin, M.G., Padbury, J. and Ross, M.G. (1992) Fetal catecholamine, cardiovascular, and neurobehavioral responses to cocaine. Am. J. Obstet. Gynecol., 167, 1616-1623.
15. Chasnoff, I.J. (1987) Perinatal effects of cocaine. Contemp. Obstet. Gynecol., 29, 164.
16. Chasnoff, I.J. (1989) Cocaine, pregnancy and the neonate. Women Health, 15, 23-35.
17. Chasnoff, I.J., Burns, W.J., Schnoll, S.H. and Burns, K.A. (1985) Cocaine use in pregnancy. N. Engl. J. Med., 313, 666-669.
18. Chasnoff, I.J., Burns, K.A. and Burns, W.J. (1987) Cocaine use in pregnancy: perinatal morbidity and mortality. Neurotoxicol. Teratol., 9, 291-293.
19. Chasnoff, I.J., Griffith, D.R., MacGregor, S., Dilkes, K. and Burns, K.A. (1989a) Temporal patterns of cocaine use in pregnancy. J. Am. Med. Assoc., 261, 1741-1744.
20. Chasnoff, I.J., Hunt, C.E., Kletter, R. and Kaplan, D. (1989b) Prenatal cocaine exposure is associated with respiratory pattern abnormalities. Am. J. Dis. Child., 143, 583-587.
21. Chasnoff, I.J., Lewis, D.E., Griffith, D.R. and Willey, S. (1989c) Cocaine and pregnancy: clinical and toxicological implications for the neonate. Clin. Chem., 35, 1276-1278.
22. Chasnoff, I.J., Landress, H.J. and Barrett, M.E. (1990) The prevalence of illicit drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N. Engl. J. Med., 332, 1202-1206.
23. Chasnoff, I.J., Griffith, D.R., Freier, C. and Murray, J. (1992) Cocaine/polydrug use in pregnancy: two year follow-up. Pediatrics, 89, 284-289.
24. Cherukuri, R., Minkoff, H., Feldman, J., Parekh, A. and Glass, L.A. (1988) A cohort study of alkaloidal cocaine ('crack') in pregnancy. Obstet. Gynecol., 72, 147-151.
25. Chouteau, M., Namerow, P.B. and Leppert, P. (1988) The effect of cocaine abuse on birth weight and gestational age. Obstet. Gynecol., 72, 351-354.
26. Christmas, J.T., Knisely, J.S., Dawson, K.S., Dinsmoor, M.J., Weber, S.E. and Schnoll, S.H. (1992) Comparison of questionnaire screening and urine toxicology for definition of pregnancy complicated by substance abuse. Obstet. Gynecol., 80, 750-754.
27. Church, M.W., Dincheff, B.A. and Gessner, P.K. (1988) Dose-dependent consequences of cocaine on pregnancy outcome in the Long-Evans rat. Neurotoxicol. Teratol., 10, 51-58.
28. Clayton, R.R. (1985) Cocaine use in the US: in a blizzard or just being snowed? In Kozel, N. and Adams, E. (eds), Cocaine Use in America: Epidemiology and Clinical Perspectives. NIDA Research Monograph 61, Department of Health and Human Services, Rockville, MD, USA, pp. 8-36.
29. Cregler, L.L. and Mark, H. (1986) Medical complications of cocaine abuse. N. Engl. J. Med., 315, 1495-1500.
30. Dattel, B.J. (1990) Substance abuse in pregnancy. Semin. Perinatol., 14, 179-187.
31. Delaney-Black, V., Covington, C. and Sokol, R.J. (1994) Maternal cocaine consumption: birth outcome and child development. Fetal Maternal Med. Rev., 6, 119-134.
32. Dicke, J.M., Verges, D.K. and Polakoski, K.L. (1993) Cocaine inhibits alanine uptake by human placental microvillus membranes vesicles. Am. J. Obstet. Gynecol., 169, 515-521.
33. Dicke, J.M., Verges, D.K. and Polakoski, K.L. (1994) The effects of cocaine on neutral amino acid uptake by human placental basal membrane vesicles. Am. J. Obstet. Gynecol., 171, 485-491.
34. Dinsmoor, M.J., Irons, S.J. and Christmas, J.T. (1994) Preterm rupture of the membranes associated with recent cocaine use. Am. J. Obstet. Gynecol., 171, 305-309.
35. Dixon, S.D. and Bejar, R. (1989) Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J. Pediatr., 115, 770-778.
36. Doberczak, T.M., Shanzer, S., Senie, R.T. and Kandall, S.R. (1988) Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J. Pediatr., 113, 354-358.
37. Dogra, V.S., Shyken, J.M., Menon, P.A., Poblete, J., Lewis, D. and Smeltzer, J.S. (1994) Neurosonographic abnormalities associated with maternal history of cocaine use in neonates of appropriate size for their gestational age. Am. J. Neuroradiol., 15, 697-702.
38. Downing, G.J., Horner, S.R. and Kilbride, H.W. (1991) Characteristics of perinatal cocaine-exposed infants with necrotizing enterocolitis. Am. J. Dis. Child., 145, 25-27.
39. Finnell, R.H., Toloyan, S., van Waes, M. and Kalivas, P.W. (1990) Preliminary evidence for a cocaine-induced embryopathy in mice. Toxicol. Appl. Pharmacol., 103, 228-237.
40. Frank, D.A., Zuckerman, B.S., Amaro, H., Aboagye, K., Bauchner, H., Cabral, H., Fried, L., Hingson, R., Kayne, H., Levenson, S.M., Parker, S., Reece, H. and Vinci, R. (1988) Cocaine use during pregnancy: prevalence and correlates. Pediatrics, 82, 888-895.
41. Frank, D.A., Breshnahan, K. and Zuckerman, B.S. (1993) Maternal cocaine use: impact on child health and development. Adv. Pediatr., 40, 65-99.
42. Frassica, J.J., Orav, E.J., Walsh, E.P. and Lipshultz, S.E. (1994) Arrythmias in children prenatally exposed to cocaine. Arch. Pediatr. Adolesc. Med., 148, 1163-1169.
43. Fulroth, R., Phillips, B. and Durand, D.J. (1989) Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Am. J. Dis. Child., 143, 905-910.
44. Gawin, F.H. and Ellinwood, E.H. (1988) Cocaine and other stimulants: actions, abuse, and treatment. N. Engl. J. Med., 318, 1173-1182.
45. Gawin, F.H. and Kleber, H.D. (1984) Cocaine abuse treatment. Ancl. Gen. Psychiatry, 41, 903-909.
46. Gillogley, K.M., Evans, A.T., Hansen, R.L., Samuels, S.J. and Batra, K.K. (1990) The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am. J. Obstet. Gynecol., 163, 1535-1542.
47. Gingras, J.L., Weese-Mayer, D.E., Hume, R.F. and O'Donnel, K.J. (1992) Cocaine and development: mechanisms of fetal toxicity and neonatal consequences of prenatal cocaine exposure. Early Hum. Dev., 31, 1-24.
48. Gingras, J.L., Muelenaer, A., Dalley, L.B. and O'Donnell, K.J. (1994) Prenatal cocaine exposure alters postnatal hypoxic arousal responses and hypercarbic ventilatory responses but not pneumocardiograms in prenatally cocaine-exposed term infants. Pediatr. Pulmonol., 18, 13-20.
49. Graham, K., Koren, G., Klein, J., Schneiderman, J. and Greenwald, M. (1989) Determination of gestational cocaine exposure by hair analysis. J. Am. Med. Assoc., 262, 3328-3330.
50. Griess, F.C., Jr and Van Wilkes, D. (1964) Effects of sympathomimetic drugs and angiotensin on the uterine vascular bed. Obstet. Gynecol., 23, 925-930.
51. Hadeed, A.J. and Siegel, S.R. (1989) Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics, 84, 205-210.
52. Hamilton, H.E., Wallace, J.E., Shimek, E.L., Land, P., Harris, S.C. and Christenson, J.G. (1977) Cocaine and benzoylecgonine excretion in humans. J. Forensic Sci., 22, 697-707.
53. Handler, A., Kistin, N., Davis, F. and Ferre, C. (1991) Cocaine use during pregnancy: perinatal outcomes. Am. J. Epidemiol., 133, 818-825.
54. Hawks, R.L., Kupin, I.J. and Colburn, R.W. (1974) Norcocaine: a pharmacologically active metabolite of cocaine found in brain. Life Sci., 15, 2189-2195.
55. Heier, L.A., Carpanzano, C.R., Mast, J., Brill, P.W., Winchester, P. and Deck, M.D.F. (1991) Maternal cocaine abuse: the spectrum of radiologic abnormalities in the neonatal CNS. Am. J. Neuroradiol., 12, 951-956.
56. Horn, P. (1992) Persistent hypertension after prenatal cocaine exposure. J. Pediatr., 121, 288-291.
57. Hoyme, H.E., Lyons-Jones, K., Dixon, S.D., Jewett, T., Hanson, J.W., et al. (1990) Prenatal cocaine exposure and fetal vascular disruption. Pediatrics, 85, 743-747.
58. Hurt, H., Brodsky, N.L., Betancourt, L., Braitman, L.E., Malmud, E. and Giannetta, J. (1995) Cocaine-exposed children: follow-up through 30 months. J. Dev. Behav. Pediatr., 16, 29-35.
59. Jain, L., Meyer, W., Moore, C., Tebbett, I., Gauthier, D. and Vidyasagar, D. (1993) Detection of fetal cocaine exposure by analysis of amniotic fluid. Obstet. Gynecol., 81, 787-790.
60. Keith, L., MacGregor, S., Friedell, S., Rosner, M., Chasnoff, I.J. and Sciarra, J.J. (1989) Substance abuse in pregnant women: recent experience at the Perinatal Center for Chemical Dependence of Northwestern Memorial Hospital. Obstet. Gynecol., 73, 715-720.
61. Kliegman, R.M., Madura, D., Kiwi, R., Eisenberg, I. and Yamashita, T. (1994) Relation of maternal cocaine use to the risks of prematurity and low birth weight. J. Pediatr., 124, 751-756.
62. Kosofsky, B.E., Wilkins, A.S., Gressens, P. and Evrard, P. (1994) Transplacental cocaine exposure: a mouse model demonstrating neuroanatomic and behavioral abnormalities. J. Child. Neurol., 9, 234-241.
63. Kramer, L.D., Locke, G.E., Ogunyemi, A. and Nelson, L. (1990) Neonatal cocaine-related seizures. J. Child Neurol., 5, 60-64.
64. Lapke, J., Goleman, T.B., Aldag, J.C. and Morgan, A.M. (1992) Developmental follow-up of cocaine exposed infants in foster care. Pediatr. Res., 31, 95A.
65. Lindsay, M.K., Peterson, H.B., Boring, J., Gramling, J., Willis, S. and Klein, L. (1992) Crack cocaine: a risk factor for human immunodeficiency virus infection type 1 among inner-city parturients. Obstet. Gynecol., 80, 981-984.
66. Lipshultz, S.E., Frassica, J.J. and Orav, E.J. (1991) Cardiovascular abnormalities in infants prenatally exposed to cocaine. J. Pediatr., 118, 44-51.
67. MacGregor, S., Keith, L.G., Bachicha, J.A. and Chasnoff, I.J. (1989) Cocaine abuse during pregnancy. Correlation between prenatal care and perinatal outcome. Obstet. Gynecol., 74, 882-885.
68. Mahalik, M.P., Gautieri, R.F. and Mann, D.E. (1980) Teratogenic potential of cocaine hydrochloride in CF-1 mice. J. Pharm. Sci., 69, 703-706.
69. Mahone, P.R., Scott, K., Sleggs, G., D'Antoni, T. and Woods, J.R., Jr (1994) Cocaine and metabolites in amniotic fluid may prolong fetal drug exposure. Am. J. Obstet. Gynecol., 171, 465-469.
70. Matera, C., Warren, W.B., Moomjy, M., Fink, D.J. and Fox, H.E. (1990) Prevalence of use of cocaine and other substances in an obstetric population. Am. J. Obstet. Gynecol., 163, 797-801.
71. McCalla, S., Minkoff, H.L., Feldman, J., Delke, I., Salwin, M., et al. (1991) The biologic and social consequences of perinatal cocaine use in an inner-city population: results of an anonymous cross-sectional study. Am. J. Obstet. Gynecol., 164, 625-630.
72. Miller, J.M., Boudreaux, M.C. and Regan, F.A. (1995) A case-control study of cocaine use in pregnancy. Am. J. Obstet. Gynecol., 172, 180-185.
73. Millicovsky, G. and DeSesso, J.M. (1980). Differential embryonic cardiovascular responses to acute maternal uterine ischemia: an in vivo microscopic study of rabbit embryos with either intact or clamped umbilical cords. Teratoloy, 22, 335-343.
74. Minkoff, H.L., McCalla, S., Delke, I., Stevens, R., Salwen, M. and Feldman, J. (1990) The relationship of cocaine use to syphilis and human immunodeficiency virus infections among inner city parturient women. Am. J. Obstet. Gynecol., 163, 521-526.
75. Mitra, S.C., Ganesh, V. and Apuzzio, J.J. (1994) Effect of maternal cocaine abuse on renal arterial flow and urine output of the fetus. Am. J. Obstet. Gynecol., 171, 1556-1559.
76. Monga, M., Chmielowiec, M.S., Andres, R.L., Troyer, L.R. and Parisi, V.M. (1994) Cocaine alters placental production of thromboxane and prostacyclin. Am. J. Obstet. Gynecol., 171, 965-969.
77. Moore, T.R., Sorg, J., Miller, L., Key, T.C. and Resnik, R. (1986) Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. Am. J. Obstet. Gynecol., 155, 883-888.
78. Mueller, B.A., Daling, J.R., Weiss, N.S. and Moore, D.E. (1990) Recreational drug use and the risk of primary infertility. Epidemiology, 1, 195-200.
79. National Institute on Drug Abuse (1991) National household survey on drug abuse: population estimates 1990. US Government Printing Office, Washington, DC, USA, DHHS Publication No. (ADM) 91-1732.
80. Neuspiel, D.R., Hamel, S.C., Hochberg, E., Greene, J. and Campbell, C. (1991) Maternal cocaine use and infant behavior. Neurotoxicol. Teratol., 13, 229-233.
81. Nunes, E.V. and Rosecan, J.S. (1987) Human neurobiology of cocaine. In Spitz, M.I. and Rosecan, J.S. (eds), Cocaine Abuse: New Directions in Treatment and Research, Bruner/Mazel, New York, NY, USA, pp. 48-94.
82. Oro, A.S. and Dixon, S.D. (1987) Perinatal cocaine and methamphetamine exposure. Maternal and neonatal correlates. J. Pediatr., 111, 571-578.
83. Osterloh, J.D. and Lee, B.L. (1989) Urine drug screening in mothers and newborns. Am. J. Dis. Child., 143, 791-793.
84. Ostrea, E.M., Brady, M.J., Parks, P.M., Asensio, D.C. and Naluz, A. (1992) Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics, 89, 107-113.
85. Parker, S., Zuckerman, B., Bauchner, H., Frank, D., Vinci, R. and Cabral, H. (1990) Jitteriness in full-term neonates: prevalence and correlates. Pediatrics, 85, 17-23.
86. Petitti, D.B. and Coleman, C. (1990) Cocaine and the risk of low birth weight. Am. J. Public Health, 80, 25-28.
87. Phibbs, C.S., Bateman, D.A. and Schwartz, R.M. (1991) The neonatal costs of maternal cocaine use. J. Am. Med. Assoc., 266, 1521-1526.
88. Plessinger, M.A. and Woods, J.R., Jr (1990) Progesterone increases cardiovascular toxicity to cocaine in nonpregnant ewes. Am. J. Obstet. Gynecol., 163, 1659-1664.
89. Racine, A., Joyce, T. and Anderson, R. (1993) The association between prenatal care and birth weight among women exposed to cocaine in New York City. J. Am. Med. Assoc., 270, 1581-1586.
90. Randall, T. (1992) Cocaine alcohol mix in body to form even longer lasting, more lethal drug. J. Am. Med. Assoc., 267, 1043-1044.
91. Rangel-Friedman, D. (1990) Effects of learned helpless paradigm on learning in infants exposed to in utero cocaine. Dissertations Abstracts International, 51, 1510-1511.
92. Richardson, G. and Day, N. (1991) Maternal and neonatal effects of moderate cocaine use during pregnancy. Neurotoxicol. Teratol., 13, 455-160.
93. Roe, D.A., Little, B.B., Bawdon, R.E. and Gilstrap, L.C. (1990) Metabolism of cocaine by human placentas: implications for fetal exposure. Am. J. Obstet. Gynecol., 163, 715-718.
94. Rosenfeld, C.R. and West, J. (1977) Circulatory response to systemic infusion of norepinephrine in the pregnant ewe. Am. J. Obstet. Gynecol., 127, 376-383.
95. Rosenstein, B.J., Wheeler, J.S. and Heid, P.L. (1990) Congenital renal abnormalities in infants with in utero cocaine exposure. J. Urol., 144, 110-112.
96. Schenker, S., Yang, Y., Johnson, R.F., Downing, J.W., Schenken, R.S., et al. (1993) The transfer of cocaine and its metabolites across the term human placenta. Clin. Pharmacol. Ther., 53, 329-339.
97. Schnider, J.W. and Chasnoff, I.J. (1992) Motor assessment of cocaine/polydrug exposed infants at age 4 months. Neurotoxicol. Teratol., 14, 97-101.
98. Seigel, R.K. (1982) Cocaine smoking. J. Psychoactive Drugs, 14, 271-325.
99. Shiono, P.H., Klebanoff, M.A., Nugent, R.P., Cotch, M.F., Wilkins, D.G., et al. (1995) The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am. J. Obstet. Gynecol., 172, 19-27.
100. Singer, L.T., Garber, R. and Kliegman, R. (1991) Neurobehavioral sequelae of fetal cocaine exposure. J. Pediatr., 119, 667-672.
101. Smith, Y.R., Dombrowski, M.P., Leach, K.C. and Kurd, W.W. (1995) Decrease in myometrial β-adrenergic receptors with prenatal cocaine. Obstet. Gynecol., 85, 357-360.
102. Spence, M.R., Williams, R., DiGregorio, G.J., Kirby-McDonnell, A. and Polansky, M. (1991) The relationship between recent cocaine use and pregnancy outcome. Obstet. Gynecol., 78, 326-329.
103. Stevenson, R.E., Kelly, J.C., Aylsworth, A.S. and Phelan, M.C. (1987) Vascular basis for neural tube defects: a hypothesis. Pediatrics, 80, 102-106.
104. Stewart, D.J., Inaba, T. and Kalow, W. (1978) N-Demethylation of cocaine in the rat and in isolated rat hepatocytes: comparison with amnio-pyrene demethylation. J. Pharmacol. Exp. Ther., 207, 171-177.
105. Stewart, D.J., Inaba, T., Lucassen, M. and Kalow, W. (1979) Cocaine metabolism: cocaine and norcaine hydrolysis by liver and serum esterase. Clin. Pharmacol. Ther., 25, 464-468.
106. Streissgurth, A., Grant, T., Barr, H.M., Brown, Z.A., Martin, J.C., et al. (1991) Cocaine and the use of alcohol and other drugs during pregnancy. Am. J. Obstet. Gynecol., 164, 1239-1243.
107. Towers, C.V., Pircon, R.A., Nageotte, M.D., Porto, M. and Garite, T.J. (1993) Cocaine intoxication presenting as preeclampsia. Obstet. Gynecol., 81, 545-547.
108. Van Allen, M.I. (1981) Fetal vascular disruptions: mechanisms and some resulting birth defects. Pediatr. Ann., 10, 219-233.
109. van de Bor, M., Walther, F.J. and Sims, M.E. (1990) Increased cerebral blood flow velocity in infants of mothers who abused cocaine. Pediatrics, 85, 733-736.
110. Vega, W.A., Kolody, B., Hwang, J. and Noble, A. (1993) Prevalence and magnitude of perinatal substance exposures in California. N. Engl. J. Med., 329, 850-854.
111. Ward, S.L.D., Bautista, D.B., Chan, L., Derry, M., Lisbin, A., et al. (1990) Sudden infant death syndrome in infants of substance-abusing mothers. J. Pediatr., 117, 876-881.
112. Webster, W.S. and Brown-Woodman, P.D.C. (1990) Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratology, 41, 689-697.
113. Webster, W.S., Lipson, A.H. and Brown-Woodman, P.D.C. (1987) Uterine trauma and limb defects. Teratology, 35, 253-260.
114. Woods J.R., Jr and Plessinger, M.A. (1990) Pregnancy increases cardiovascular toxicity in cocaine. Am. J. Obstet. Gynecol., 162, 529-535.
115. Woods, J.R., Jr, Plessinger, M.A. and Clark, K.E. (1987) Effect of cocaine on uterine blood flow and fetal oxygenation. J. Am. Med. Assoc., 257, 957-961.
116. Woods, J.R., Jr, Plessinger, M.A., Scott, K.J. and Miller, R.K. (1989) Prenatal cocaine exposure to the fetus: a sheep model for cardiovascular evaluation. Ann. N.Y. Acad. Sci., 562, 267-279.
117. Woods, J.R., Jr, Scott, K.J. and Plessinger, M.A. (1994) Pregnancy enhances cocaine's actions on the heart and within the peripheral circulation. Am. J. Obstet. Gynecol., 170, 1033-1035.
118. Yazigi, R.A., Odem, R.R. and Polakoski, K.L. (1991) Demonstration of specific binding of cocaine to human spermatozoa. J. Am. Med. Assoc., 266, 1956-1959.
119. Zuckerman, B., Frank, D.A., Hingson, R., Amaro, H., Levenson, S.M., et al. (1989) Effects of maternal marijuana and cocaine use on fetal growth. N. Engl. J. Med., 320, 762-768.